Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
We compare the Sp 500 funds to reveal which has the lowest fees in 2024, highlighting expense ratios and fund structures to help you select wisely.
27,979 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Investors are watching SpaceX like a rocket on countdown. This article translates historical IPO patterns into a six-...
A promising AI-driven play could redefine long-term portfolios. Learn why this stock might be a once-in-a-decade inve...
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
July can bring clear catalysts for Disney stock investors. This guide highlights three dates to watch, explains why t...
Toyota strengthens its global cash-flow engine with hybrids and expanding markets, while Ford grapples with EV losses...
Ripple (XRP) news today tracks a flurry of partnerships and a pivotal EU license that could unlock broader use of the...
As the crypto bill enters its final stretch, democratic opposition clarity grows. Lawmakers argue the measure needs s...
A billionaire envoy sails a luxury superyacht along Italy’s coast, drawing protests in Venice and raising questions a...
Curious if you can win the lottery of Social Security—that $5,251-a-month top payout in 2026? It hinges on work credi...
Illinois and Hawaii join Wisconsin and Washington in tightening real estate listing rules, signaling a broader state-...
Portillo's has faced growth and branding challenges that threaten its future. This guide breaks down what a comeback ...